HOME >> MEDICINE >> NEWS
HIV-1 protease inhibitors: Effective against malaria?

Protease inhibitors used to treat HIV-1 infection may also be effective for treatment or prevention of malaria, according to a study published in the December 15 issue of The Journal of Infectious Diseases, now available online. The study found protease inhibitors inhibited the growth of P. falciparum, the malaria parasite that causes most disease. These findings may also expose a previously unexplored vulnerability in the parasite that could lead to a new class of anti-malarial drug. While the effects of such drugs on co-infection need to be investigated, the study's findings may be especially significant in sub-Saharan Africa and other areas of the developing world where there are high rates of HIV and malaria co-infection.

Scientists from the Queensland Institute of Medical Research tested the effects of the protease inhibitors saquinavir, ritonavir, nelfinavir, amprenavir, and indinavir, as well as the non-nucleoside reverse transcriptase inhibitor nevirapine, on a drug-resistant line of P. falciparum. Saquinavir, ritonavir, and indinavir all inhibited parasite growth in vitro at levels routinely achieved in human patients, with saquinavir and ritonavir showing the most potent effect on the parasite. Saquinavir was most effective in the study and was equally effective on chloroquine-sensitive and -resistant parasite lines, while nelfinavir and amprenavir did not demonstrate anti-malarial activity. The research builds on a previous study that demonstrated antiretroviral agents can reduce the adhesion of P. falciparum-infected erythrocytes to endothelial surfaces.

The authors believe that the antiretroviral protease inhibitors attack the malaria parasite in ways that current antimalarial treatments do not. While the mode of antimalarial action of the drugs was not uncovered in the study, the authors hypothesize that the antiretrovirals inhibit an aspartyl protease, which helps the parasite digest hemoglobin and is located on the food vacuole of the
'"/>

Contact: Steve Baragona
sbaragona@idsociety.org
703-299-0412
Infectious Diseases Society of America
8-Nov-2004


Page: 1 2

Related medicine news :

1. HIV-1 spread through six transmission lines in the UK
2. Virco establishes comprehensive set of clinical cutoffs for the vircoTYPE HIV-1 resistance test
3. Supervised treatment interruptions fail to control HIV-1 viremia
4. Potential low-cost options for monitoring HIV-1-infected children in less-developed countries
5. Substantial survival increase after highly active antiretroviral therapy for HIV-1 infection
6. Antiretrovirals reduce mother-to-child HIV-1 transmission when started after childbirth
7. Pet scans could provide insight into HIV-1 progression
8. Further evidence for effectiveness of nevirapine in reducing mother-to-child HIV-1 transmission
9. Spermicide gel could increase risk of HIV-1 infection
10. Timely antiretroviral therapy essential for best prognosis in people with HIV-1 infection
11. Reduction in HIV-1 incidence among rural Ugandans gives hope to other African countries

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/1/2020)... ... September 01, 2020 , ... Feeding Matters , the first ... Pediatric Feeding Disorder (PFD), is pleased to announce that the U.S. Centers for Disease ... (R code) in the next edition of the U.S. International Classification of Diseases ...
(Date:8/31/2020)... ... 2020 , ... Just found out your dear friend has cancer? , It’s hard to hear ... member shares their diagnosis. Once the shock wears off, the questions and fears can be ... the best ways to help? Words are failing me. I’m scared. I want to DO ...
(Date:8/31/2020)... ... August 31, 2020 , ... Smile Brands Inc., ... in the United States, today announced the grand opening of another affiliated ... Patients will enjoy convenient hours, a comfortable office, and full-service care at the ...
(Date:8/31/2020)... ... August 31, 2020 , ... Bonde ... for patients with advanced heart failure, today announced that the company has been ... of $555,358 from the National Heart, Lung, and Blood Institute of the National ...
(Date:8/28/2020)... ... August 28, 2020 , ... With ... set out to continue helping the specialty-diet community connect with great, gluten-free brands. ... get coupons, enter giveaways, chat with brands & watch over 50 educational classes... ...
Breaking Medicine News(10 mins):
(Date:9/3/2020)... ... ... Using Analysis of Variance — A Practical Approach:, Perform Statistical Analysis Without ... https://www.fdanews.com/anova , How much would it help one’s Quality Management System if ... 90 minutes, one can master a powerful statistical technique in that time — Analysis ...
(Date:9/2/2020)... Texas (PRWEB) , ... September ... ... in the Fight Against Covid-19 , Advanced Penetration Technology, LLC, (APT) a ... solutions for patients utilizing non-prescription, Over The Counter (OTC) products, was today ...
(Date:9/1/2020)... ... September 01, 2020 , ... Mara C. Weinstein Velez, ... at the University of Rochester Medical Center, in Upstate New York. She completed ... with clinical faculty from the Harvard and Yale Departments of Dermatology and is ...
Breaking Medicine Technology:
Cached News: